The first compound heterozygous mutations in SLC12A3 and PDX1 genes: a unique presentation of Gitelman syndrome with distinct insulin resistance and familial diabetes insights

被引:4
作者
Yin, Yaqi [1 ]
Li, Liqin [2 ]
Yu, Songyan [3 ]
Xin, Yu [4 ]
Zhu, Lili [5 ]
Hu, Xiao [6 ]
Chen, Kang [1 ]
Gu, Weijun [1 ]
Mu, Yiming [1 ]
Zang, Li [1 ]
Lyu, Zhaohui [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Endocrinol, Beijing, Peoples R China
[2] Baoding 1 Cent Hosp, Dept Endocrinol, Baoding, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Endocrinol, Beijing, Peoples R China
[4] Nankai Univ, Sch Med, Tianjin, Peoples R China
[5] TaiYuan 8 People Hosp, Dept Endocrinol & Cardiol, Taiyuan, Peoples R China
[6] 63790th Hosp Chinese Peoples Liberat Army, Dept Internal Med, Xichang, Peoples R China
关键词
Gitelman syndrome; PDX1; MODY4; insulin resistance; CHINESE PATIENTS; GLUCOSE-METABOLISM; NACL COTRANSPORTER; THIAZIDE; OBESITY; VARIANT; LOCALIZATION; TOLERANCE; PANCREAS; AGENESIS;
D O I
10.3389/fendo.2023.1327729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Gitelman Syndrome (GS) patients frequently exhibit disrupted glucose metabolism, attributed to hypokalemia, hypomagnesemia and heightened aldosterone. This study delved into the genetic underpinnings linked to insulin resistance and diabetes in a GS patient, contextualized within his family history. Methods: The hydrochlorothiazide and furosemide loading test were performed to ascertain the presence of GS. Oral glucose tolerance test (OGTT) evaluated glucose metabolism and insulin sensitivity. Whole-exome sequencing, validated by Sanger sequencing, was employed to confirm gene mutations, which were then tracked among the patient's relatives. Results: Symptoms and laboratory examination confirmed the clinical diagnosis of GS. Comprehensive whole-exome sequencing, augmented by Sanger sequencing validation, revealed a compound heterozygous mutation within the SLC12A3 gene (c.1108G>C in exon 9, c.676G>A in exon 5 and c.2398G>A in exon 20) in the patient. The OGTT affirmed diabetes and heightened insulin resistance, distinct from previous patients with GS we evaluated. Further genetic analysis identified a missense heterozygous mutation (c.97C>G in exon 1) within the PDX1 gene, inherited from the patient's diabetic mother without GS. Furthermore, the patient's brother, with impaired glucose tolerance but regular potassium levels, also bore this mutation, hinting at additional impacts of the PDX1 gene mutation on glucose metabolism regulation beyond the known impacts of GS. Conclusion: This study unveils unprecedented compound heterozygous mutations in the SLC12A3 and PDX1 genes in a GS patient. These findings illuminate the potential complex genetic factors influencing glucose metabolism disruptions in GS. Take-home message: This research uncovers a novel combination of SLC12A3 and PDX1 gene mutations in a Gitelman Syndrome patient, revealing intricate genetic factors that potentially disrupt glucose metabolism and shedding light on familial diabetes links.
引用
收藏
页数:11
相关论文
共 42 条
[1]   β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes [J].
Ahlgren, U ;
Jonsson, J ;
Jonsson, L ;
Simu, K ;
Edlund, H .
GENES & DEVELOPMENT, 1998, 12 (12) :1763-1768
[2]   Resistance to Insulin in Patients with Gitelman Syndrome and a Subtle Intermediate Phenotype in Heterozygous Carriers: A Cross-Sectional Study [J].
Blanchard, Anne ;
Vallet, Marion ;
Dubourg, Laurence ;
Hureaux, Marguerite ;
Allard, Julien ;
Haymann, Jean-Philippe ;
de la Faille, Renaud ;
Arnoux, Armelle ;
Dinut, Aurelie ;
Bergerot, Damien ;
Becker, Pierre-Hadrien ;
Courand, Pierre-Yves ;
Baron, Stephanie ;
Houillier, Pascal ;
Tack, Ivan ;
Devuyst, Olivier ;
Jeunemaitre, Xavier ;
Azizi, Michel ;
Vargas-Poussou, Rosa .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (08) :1533-1544
[3]   Insulin signaling, glucose metabolism, and the angiotensin II signaling system -: Studies in Bartter's Gitelman's syndromes [J].
Davis, PA ;
Pagnin, E ;
Semplicini, A ;
Avogaro, A ;
Calò, LA .
DIABETES CARE, 2006, 29 (02) :469-471
[4]   A novel mutation of SLC12A3 gene causing Gitelman syndrome [J].
De Silva, Neomal ;
Pathmanathan, Sivatharshya ;
Sumanatilleke, Manilka ;
Dematapitiya, Chinthana ;
Dissanayake, Preethi ;
Wijenayake, Umesha ;
Subasinghe, Vindya ;
Dissanayake, Vajira .
SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
[5]  
Fajans SB GI., 2000, Diabetes Mellitus, V70, P691
[6]   Mechanisms of disease: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. [J].
Fajans, SS ;
Bell, GI ;
Polonsky, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :971-980
[7]   Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60 [J].
Fajans, Stefan S. ;
Bell, Graeme I. ;
Paz, Veronica P. ;
Below, Jennifer E. ;
Cox, Nancy J. ;
Martin, Catherine ;
Thomas, Inas H. ;
Chen, Ming .
TRANSLATIONAL RESEARCH, 2010, 156 (01) :7-14
[8]  
Gitelman Syndrome Collaborative Study Group, 2017, Zhonghua Nei Ke Za Zhi, V56, P712, DOI 10.3760/cma.j.issn.0578-1426.2017.09.021
[9]   Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? [J].
Gommers, Lisanne M. M. ;
Hoenderop, Joost G. J. ;
Bindels, Rene J. M. ;
de Baaij, Jeroen H. F. .
DIABETES, 2016, 65 (01) :3-13
[10]   Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1 [J].
Gonsorcikova, Lucie ;
Pruhova, Stepanka ;
Cinek, Ondrej ;
Ek, Jakob ;
Pelikanova, Terezie ;
Jorgensen, Torben ;
Eiberg, Hans ;
Pedersen, Oluf ;
Hansen, Torben ;
Lebl, Jan .
PEDIATRIC DIABETES, 2008, 9 (04) :367-372